Active	Status	Sponsor type	Region	Phase	Filter
14 Active 1 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schöls, Ludger
NCT06623890: A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it for the First Time	Recruiting	N/A	300	Europe, US, RoW	Omaveloxolone, SKYCLARYS, BIIB141	Reata, a wholly owned subsidiary of Biogen	Friedreich Ataxia	10/29	10/29
Schüle, Rebecca
No trials found
Dillmann, Katrin
No trials found
Krägeloh-Mann, Ingeborg
No trials found
Döbler-Neumann, Marion
No trials found